• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Three-year cases report of Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) in Thyroid cancer from 2014 – 2017

Three-year cases report of Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) in Thyroid cancer from 2014 – 2017

Thanadeth Vongjarukorn, MD, Khwannara Ketwong, MD, Isariya Jongekkasit, MD, Pornpeera Jitpratoom, MD, Thanyawat Sasanakietkul, MD, Angkoon Anuwong, MD. Police General Hospital

Introduction: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA)’s an upcoming surgical technique. There’re total of 680 TOETVA cases performed in Police General Hospital from March 2014 – July 2017. There’s still less report about thyroid cancer cases in TOETVA. This study reviews all cases of thyroid cancer which surgery were performed. There were 47cases of TOETVA in thyroid cancer and 7cases of opened thyroidectomy. 

Objective: To review and report in terms of surgical outcome, complication, post-surgical treatment and recurrence in all cases of thyroid cancer surgery, especially in TOETVA technique. 

Material and Methods: From March 2014 – July 2017 in Police General Hospital, a total of 680 patients underwent TOETVA with 47cases of TOETVA in thyroid cancer and 7cases of opened thyroid surgery in thyroid cancer. All patients were recorded in multiple parameters. 

Results: This study have total of 54 thyroid cancer cases which 7cases (13%) were male and 47cases (87%) were female, with an average age of 38.

Most clinical presentation was thyroid mass or nodule which was at 52cases (96.3%), 1case (3.7%) was non -toxic goiter and 1case (3.7%) was Grave disease. The clinical presentation mean time was 2.6years (2weeks-13years). There were 36cases (66.7%) with a mass at right lobe, 15cases (27.8%) with a mass at left lobe, and 3cases (5.6%) with mass at both lobes. The size of thyroid mass was 3.5 ±2.3centimeters (1-15centimeters). There were 49cases (90.7%) had euthyroid, 1case (1.85%) had subclinical hyperthyroid, 2cases (3.7%) had subclinical hypothyroid, and 2cases (3.7%) had hyperthyroid. 

For type of surgery, there were 47cases (87.04%) of TOETVA surgery and 7cases (12.96%) of opened total thyroidectomy. Most patients at 41cases (75.9%) didn't have any post-operative complication. And there were hypothyroid 5cases (9.35%), transient hypocalcemia with no symptom 6cases (11.1%), and transient hoarseness 2cases (3.7%). 

After TOETVA surgery performed, 24cases (44.4%) were redo completion thyroidectomy, 19cases (79.2%) were transaxillary completion thyroidectomy, 4cases (16.7%) were redo TOETVA, and 1case (4.2%) deny for re-operation. And 18cases (75%) didn’t have any complication after redo surgery, 3cases (12.5%) were hypothyroid, 2cases (8.32%) were hypocalcemia and hypoparathyroid, and 1case (4.2%) was transient hoarseness. 

After did thyroidectomy, ultrasound neck shown that 47cases had no residual or recurrence thyroid mass, 7cases had residual thyroid tissue. All cases received radioactive iodine ablation. Radionuclide total body scan showed no evidence of distant functioning metastasis. 

Conclusion: Three-year short-term followed up TOETVA in thyroid cancer has shown less complication and no recurrence cancer. 


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87056

Program Number: P676

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

381

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals